Effectiveness of two doses of Euvichol-plus oral cholera vaccine in response to the 2017/2018 outbreak: a matched case–control study in Lusaka, Zambia

Author:

Sialubanje CephasORCID,Kapina Muzala,Chewe Orbrie,Matapo Belem Blamwell,Ngomah Albertina MoraesORCID,Gianetti Brittany,Ngosa William,Kasonde Mpanga,Musonda Kunda,Mulenga ModestORCID,Michelo C,Sinyange Nyambe,Bobo Patricia,Zyambo Khozya,Mazyanga Lucy,Bakyaita Nathan,Mukonka Victor M

Abstract

IntroductionZambia experienced a major cholera outbreak in 2017–2018, with more than 5905 cases reported countrywide, predominantly from the peri-urban slums of Lusaka city. The WHO recommends the use of oral cholera vaccines (OCVs) together with traditional control measures, including health promotion, provision of safe water and improving sanitation, in cholera endemic areas and during cholera outbreaks. In response to this outbreak, the Zambian government implemented the OVC campaign and administered the Euvichol-plus vaccine in the high-risk subdistricts of Lusaka. Although OCVs have been shown to be effective in preventing cholera infection in cholera endemic and outbreak settings, the effectiveness of the Euvichol-plus vaccine has not yet been evaluated in Zambia. This study aimed to determine the effectiveness of two doses of OCV administered during the 2017/2018 vaccination campaign.MethodsWe conducted a matched case–control study involving 79 cases and 316 controls following the mass vaccination campaign in the four subdistricts of Lusaka (Chawama, Chipata, Kanyama and Matero). Matching of controls was based on the place of residence, age and sex. Conditional logistic regression was used for analysis. Adjusted OR (AOR), 95% CI and vaccine effectiveness (1-AOR) for two doses of Euvichol-plus vaccine and any dose were estimated (p<0.05).ResultsThe AOR vaccine effectiveness for two doses of Euvichol-plus OCV was 81.0% (95% CI 66.0% to 78.0%; p<0.01). Secondary analysis showed that vaccine effectiveness for any dose was 74.0% (95% CI 50.0% to 86.0%; p<0.01).ConclusionThese findings show that two doses of Euvichol-plus OCV are effective in a cholera outbreak setting in Lusaka, Zambia. The findings also indicate that two doses are more effective than a single dose and thus support the use of two doses of the vaccine as part of an integrated intervention to cholera control during outbreaks.

Funder

Ministry of Health

World Health Organization

Publisher

BMJ

Subject

General Medicine

Reference26 articles.

1. WHO . Cholera, 2022. Available: https://www.who.int/news-room/fact-sheets/detail/cholera [Accessed 10 July 2022].

2. Ali M , Lopez AL , You YA . The global burden of cholera. bull World health organ 2012;90:209–18.

3. Identification of cholera hotspots in Zambia: a spatiotemporal analysis of cholera data from 2008 to 2017;Mwaba;PLoS Negl Trop Dis,2020

4. Cholera epidemiology in Zambia from 2000 to 2010: implications for improving cholera prevention and control strategies in the country;Olu;East Afr Med J,2013

5. WHO . Zambia cholera outbreak situation reports, 2018. Available: https://www.afro.who.int/countries/zambia/situation-reports/cholera [Accessed 10 July 2022].

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3